New Delhi, Nov 6, 2025: Prime Minister Narendra Modi on Wednesday formally dedicated three pioneering innovations to the nation during the ongoing Emerging Science, Technology & Innovation Conclave (ESTIC) 2025, underscoring India’s growing capabilities in high-end scientific research and technology. The innovations, spanning quantum computing and healthcare, reflect India’s ambitions to establish itself as a global hub for advanced technologies while simultaneously addressing pressing healthcare challenges.

The three technologies unveiled at ESTIC 2025 comprise two breakthroughs in quantum computing developed by Bengaluru-based startups and an indigenously developed cancer therapy pioneered by the Indian Institute of Technology (IIT) Bombay and its spin-off startup, ImmunoACT. Together, these innovations represent a convergence of cutting-edge digital and biomedical research, showcasing India’s commitment to advancing scientific frontiers.

Among the quantum computing innovations is QSIP (Quantum Random Number Generator System in Package), developed by QNu Pvt Labs. QSIP represents a critical step forward in securing India’s cyber and digital infrastructure, particularly as nations worldwide brace for the potential disruptions posed by quantum computing to traditional encryption methods. The system generates quantum-certified random numbers derived from quantum processes, which can be used for encryption and decryption of sensitive data. This capability ensures a level of security that is resistant to attacks from both classical and future quantum computers, making it a foundational tool for critical government and financial infrastructure, telecommunications, and defence systems.

The second quantum innovation dedicated by the Prime Minister is the 25-qubit Quantum Processing Unit (QPU), developed by QpiAI, one of the eight startups selected under India’s National Quantum Mission 2023. Known as QpiAI-Indus, this is India’s first full-stack quantum computer that integrates all technological layers, featuring 25 superconducting qubits. According to QpiAI, the 25-qubit machine is capable of performing complex calculations at unprecedented speeds, enabling simulations and analyses that were previously unfeasible for classical computers. Its potential applications are extensive, including optimization in pharmaceuticals, materials science, logistics, and manufacturing. The startup has positioned QpiAI-Indus as a platform for quantum research and industrial application, allowing Indian scientists and engineers to explore practical solutions to both scientific and commercial problems.

On the healthcare front, Prime Minister Modi dedicated NexCAR19, India’s first indigenous CAR-T cell general therapy for cancer, developed by the IIT Bombay spin-off ImmunoACT. CAR-T (Chimeric Antigen Receptor T-cell) therapy represents one of the most advanced treatments in oncology, involving the genetic modification of a patient’s own immune cells to target and destroy cancerous cells. NexCAR19 is designed to be accessible and affordable, marking a milestone in India’s efforts to provide advanced gene therapies to a larger population without compromising scientific rigor or patient safety.

The therapy has already been administered to over 500 patients across the country, with early results indicating significant improvements in treatment outcomes. It was developed with support from the BioNest initiative under the Biotechnology Industry Research Assistance Council (BIRAC), which provided funding, mentorship, and access to research resources. ImmunoACT was incubated at IIT Bombay’s Society of Innovation and Entrepreneurship (SINE), which has historically served as a launchpad for technology-driven startups aiming to bring research innovations to practical applications.

In a statement released by the Prime Minister’s Office, Modi highlighted the transformative potential of these innovations, stating, “These three technologies reflect India’s growing capabilities in frontier research and development. QSIP and the 25-qubit QPU strengthen our digital and cyber infrastructure, while NexCAR19 offers hope to patients battling cancer, demonstrating that advanced treatments can be made both affordable and accessible.” The statement emphasised that the government sees these innovations as emblematic of India’s scientific self-reliance and global competitiveness.

Dr Rahul Purwar, professor at IIT Bombay and co-founder of ImmunoACT, elaborated on NexCAR19, noting that the therapy represents a significant step toward democratizing access to high-end cancer treatment. “NexCAR19 has made it possible to bring gene and cell therapy into the mainstream healthcare system without sacrificing the rigor and quality standards that such treatments demand,” he said. He also highlighted the HOPE Initiative, launched by ImmunoACT as an integrated support ecosystem for patients and caregivers navigating advanced treatments, providing educational, psychological, and logistical support alongside clinical care.

The ESTIC 2025 event itself serves as a platform to showcase India’s growing capabilities in science, technology, and innovation. By dedicating these three technologies, the Prime Minister reinforced India’s broader vision of integrating high-end research with practical applications that benefit society, strengthen national security, and drive economic growth. Experts attending the conclave noted that such demonstrations of indigenous innovation signal India’s readiness to compete on the global stage in emerging technologies such as quantum computing, cybersecurity, and precision medicine.

Quantum computing, in particular, has been identified as a strategic technology with wide-ranging implications. QSIP’s quantum-certified randomness allows for highly secure communications, which is essential for protecting sensitive national and commercial data in an era where quantum attacks are becoming a tangible risk. The 25-qubit QPU, meanwhile, provides a platform for solving complex scientific and industrial problems, and its development within India underscores the country’s intent to build domestic capabilities in a field that is still nascent globally.

In the healthcare domain, the introduction of NexCAR19 signals India’s emergence as a key player in advanced biotherapeutics. While CAR-T therapy has been available in select countries for over a decade, its prohibitive cost has limited access for most patients. By developing an indigenously produced therapy that is affordable, ImmunoACT has demonstrated that high-impact medical innovation can be locally developed and scaled to meet domestic needs. This aligns with broader government efforts to strengthen India’s biotechnology ecosystem and make advanced medical treatments more widely accessible.

Together, these three innovations showcase the dual approach India is pursuing: strengthening technological sovereignty and preparing the country for the next wave of global scientific advancements, while ensuring that cutting-edge healthcare solutions are both accessible and effective. Government officials attending ESTIC 2025 noted that such initiatives reflect a strategic alignment of national research priorities with societal needs, an approach that has been central to India’s innovation policy over the past decade.

As India dedicates QSIP, the 25-qubit QPU, and NexCAR19 to the nation, the message from the Prime Minister is clear: investment in frontier science and technology is not just a matter of academic achievement, but a tool for societal transformation, economic growth, and national security. Observers at the conclave noted that the successful development of these technologies within India demonstrates the potential of collaboration between research institutions, startups, and government programs to produce world-class innovations.

The ESTIC 2025 event is expected to feature further discussions on emerging technologies, artificial intelligence, biotechnology, and quantum computing, creating an ecosystem for collaboration between policymakers, researchers, and entrepreneurs. With these three innovations now officially dedicated to the nation, India positions itself at the intersection of scientific excellence and practical application, setting a benchmark for future initiatives in technology and healthcare.

In conclusion, Prime Minister Modi’s dedication of QSIP, the 25-qubit QPU, and NexCAR19 underscores India’s commitment to leveraging indigenous innovation for societal benefit. By advancing quantum computing and delivering affordable gene therapy, the country not only strengthens its technological and healthcare capabilities but also demonstrates the potential for domestic research institutions and startups to shape India’s role as a global leader in science and technology in the coming decade.